AbbVie
ABBV
ABBV
3,091 hedge funds and large institutions have $183B invested in AbbVie in 2023 Q3 according to their latest regulatory filings, with 175 funds opening new positions, 1,270 increasing their positions, 1,272 reducing their positions, and 106 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3,091
Holders Change
+32
Holders Change %
+1.05%
% of All Funds
49.28%
Holding in Top 10
222
Holding in Top 10 Change
+52
Holding in Top 10 Change %
+30.59%
% of All Funds
3.54%
New
175
Increased
1,270
Reduced
1,272
Closed
106
Calls
$3.77B
Puts
$2.19B
Net Calls
+$1.58B
Net Calls Change
+$712M
Top Buyers
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$896M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$448M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$216M |
| 4 |
Goldman Sachs
New York
|
+$211M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$187M |
Top Sellers
| 1 |
VOYA Investment Management
Atlanta,
Georgia
|
-$241M |
| 2 |
JPMorgan Chase & Co
New York
|
-$230M |
| 3 |
Comerica Bank
Dallas,
Texas
|
-$220M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$182M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$176M |